128 related articles for article (PubMed ID: 18849166)
1. The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach.
Fan Y; Lai MH; Sullivan K; Popiolek M; Andree TH; Dollings P; Pausch MH
Bioorg Med Chem Lett; 2008 Nov; 18(21):5789-91. PubMed ID: 18849166
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow.
Markt P; Feldmann C; Rollinger JM; Raduner S; Schuster D; Kirchmair J; Distinto S; Spitzer GM; Wolber G; Laggner C; Altmann KH; Langer T; Gertsch J
J Med Chem; 2009 Jan; 52(2):369-78. PubMed ID: 19143566
[TBL] [Abstract][Full Text] [Related]
3. Differential involvement of intracellular domains of the rat NTS1 neurotensin receptor in coupling to G proteins: a molecular basis for agonist-directed trafficking of receptor stimulus.
Skrzydelski D; Lhiaubet AM; Lebeau A; Forgez P; Yamada M; Hermans E; Rostene W; Pelaprat D
Mol Pharmacol; 2003 Aug; 64(2):421-9. PubMed ID: 12869647
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
Ahmed A; Choo H; Cho YS; Park WK; Pae AN
Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
[TBL] [Abstract][Full Text] [Related]
5. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
[TBL] [Abstract][Full Text] [Related]
6. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.
Zhang R; Yan PK; Zhou CH; Liao JY; Wang MW
Acta Pharmacol Sin; 2007 Jan; 28(1):125-31. PubMed ID: 17184592
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor.
Geldenhuys WJ; Kuzenko SR; Simmons MA
J Med Chem; 2010 Nov; 53(22):8080-8. PubMed ID: 21047106
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation.
Souazé F; Forgez P
Peptides; 2006 Oct; 27(10):2493-501. PubMed ID: 16889873
[TBL] [Abstract][Full Text] [Related]
10. Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand.
Pratsch G; Unfried JF; Einsiedel J; Plomer M; Hübner H; Gmeiner P; Heinrich MR
Org Biomol Chem; 2011 May; 9(10):3746-52. PubMed ID: 21472182
[TBL] [Abstract][Full Text] [Related]
11. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.
Kitabgi P
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):764-76. PubMed ID: 12630297
[TBL] [Abstract][Full Text] [Related]
12. The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay.
Thomas JB; Navarro H; Warner KR; Gilmour B
Bioorg Med Chem Lett; 2009 Mar; 19(5):1438-41. PubMed ID: 19195889
[TBL] [Abstract][Full Text] [Related]
13. Functional domains of the subtype 1 neurotensin receptor (NTS1).
Kitabgi P
Peptides; 2006 Oct; 27(10):2461-8. PubMed ID: 16901586
[TBL] [Abstract][Full Text] [Related]
14. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
[TBL] [Abstract][Full Text] [Related]
15. Identification of "latent hits" in compound screening collections.
Mestres J; Veeneman GH
J Med Chem; 2003 Jul; 46(16):3441-4. PubMed ID: 12877579
[TBL] [Abstract][Full Text] [Related]
16. Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.
Leffler A; Ahlstedt I; Engberg S; Svensson A; Billger M; Oberg L; Bjursell MK; Lindström E; von Mentzer B
Biochem Pharmacol; 2009 May; 77(9):1522-30. PubMed ID: 19426690
[TBL] [Abstract][Full Text] [Related]
17. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.
Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T
Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055
[TBL] [Abstract][Full Text] [Related]
18. Receptor reserve reflects differential intrinsic efficacy associated with opioid diastereomers.
Carliss RD; Keefer JF; Perschke S; Welch S; Rich TC; Weissman AD
Pharmacol Biochem Behav; 2009 May; 92(3):495-502. PubMed ID: 19463265
[TBL] [Abstract][Full Text] [Related]
19. Identification of small molecule antagonists of the human mas-related gene-X1 receptor.
Kunapuli P; Lee S; Zheng W; Alberts M; Kornienko O; Mull R; Kreamer A; Hwang JI; Simon MI; Strulovici B
Anal Biochem; 2006 Apr; 351(1):50-61. PubMed ID: 16510108
[TBL] [Abstract][Full Text] [Related]
20. Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2.
Thomas JB; Giddings AM; Wiethe RW; Olepu S; Warner KR; Sarret P; Gendron L; Longpre JM; Zhang Y; Runyon SP; Gilmour BP
J Med Chem; 2014 Sep; 57(17):7472-7. PubMed ID: 25157640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
